HSBC Holdings’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-454,149
| Closed | -$83.5M | – | 3255 |
|
|
2021
Q2 | $83.5M | Sell |
454,149
-181,762
| -29% | -$31.2M | 0.1% | 211 |
|
|
2021
Q1 | $97.6M | Buy |
635,911
+262,234
| +70% | +$40.6M | 0.13% | 168 |
|
|
2020
Q4 | $58.3M | Buy |
373,677
+89,581
| +32% | +$11.5M | 0.09% | 247 |
|
|
2020
Q3 | $32.4M | Sell |
284,096
-16,438
| -5% | -$1.77M | 0.06% | 330 |
|
|
2020
Q2 | $33.7M | Sell |
300,534
-30,661
| -9% | -$3.26M | 0.07% | 284 |
|
|
2020
Q1 | $29.6M | Buy |
331,195
+130,981
| +65% | +$12.9M | 0.08% | 263 |
|
|
2019
Q4 | $21.5M | Sell |
200,214
-157,494
| -44% | -$16.8M | 0.04% | 494 |
|
|
2019
Q3 | $35M | Buy |
357,708
+220,629
| +161% | +$24.9M | 0.08% | 323 |
|
|
2019
Q2 | $18M | Sell |
137,079
-5,264
| -4% | -$678K | 0.04% | 549 |
|
|
2019
Q1 | $19.2M | Sell |
142,343
-10,945
| -7% | -$1.36M | 0.04% | 525 |
|
|
2018
Q4 | $14.9M | Buy |
153,288
+11,784
| +8% | +$1.39M | 0.04% | 622 |
|
|
2018
Q3 | $19.7M | Buy |
141,504
+5,672
| +4% | +$712K | 0.04% | 558 |
|
|
2018
Q2 | $16.9M | Sell |
135,832
-47,835
| -26% | -$5.59M | 0.04% | 560 |
|
|
2018
Q1 | $20.5M | Sell |
183,667
-99,396
| -35% | -$11.9M | 0.03% | 536 |
|
|
2017
Q4 | $33.9M | Sell |
283,063
-47,995
| -14% | -$5.84M | 0.05% | 355 |
|
|
2017
Q3 | $46.4M | Buy |
331,058
+152,217
| +85% | +$20.7M | 0.09% | 252 |
|
|
2017
Q2 | $21.8M | Buy |
178,841
+41,381
| +30% | +$4.82M | 0.05% | 479 |
|
|
2017
Q1 | $16.7M | Buy |
137,460
+13,001
| +10% | +$1.68M | 0.04% | 522 |
|
|
2016
Q4 | $15.2M | Buy |
124,459
+14,920
| +14% | +$1.83M | 0.05% | 568 |
|
|
2016
Q3 | $13.4M | Buy |
109,539
+8,765
| +9% | +$1.13M | 0.04% | 565 |
|
|
2016
Q2 | $11.8M | Sell |
100,774
-5,453
| -5% | -$774K | 0.04% | 605 |
|
|
2016
Q1 | $14.8M | Sell |
106,227
-4,714
| -4% | -$692K | 0.05% | 506 |
|
|
2015
Q4 | $21.2M | Sell |
110,941
-12,376
| -10% | -$2.16M | 0.06% | 416 |
|
|
2015
Q3 | $19.3M | Sell |
123,317
-148,047
| -55% | -$27M | 0.05% | 416 |
|
|
2015
Q2 | $49.1M | Sell |
271,364
-27,435
| -9% | -$4.73M | 0.11% | 214 |
|
|
2015
Q1 | $51.8M | Buy |
298,799
+52,488
| +21% | +$9.5M | 0.11% | 215 |
|
|
2014
Q4 | $45.6M | Buy |
246,311
+43,131
| +21% | +$7.99M | 0.11% | 228 |
|
|
2014
Q3 | $33.7M | Buy |
203,180
+6,385
| +3% | +$1.05M | 0.08% | 275 |
|
|
2014
Q2 | $30.8M | Buy |
196,795
+14,981
| +8% | +$2.37M | 0.07% | 298 |
|
|
2014
Q1 | $27.6M | Sell |
181,814
-24,571
| -12% | -$3.91M | 0.07% | 309 |
|
|
2013
Q4 | $27.4M | Sell |
206,385
-4,580
| -2% | -$550K | 0.08% | 314 |
|
|
2013
Q3 | $24.5M | Buy |
210,965
+157,112
| +292% | +$17.2M | 0.08% | 327 |
|
|
2013
Q2 | $4.97M | Buy |
+53,853
| New | +$5.19M | 0.02% | 681 |
|
Other funds holding ALXN
BCI
NICM
TAIM
RG
CFO
MAM